We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Innovaderma Plc | IDP | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 29.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 29.00 | 29.00 |
| Top Posts |
|---|
Posted at 15/7/2022 12:00 by km18 ...from a few months ago...InnovaDerma plc comprises departments engaged in developing clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation. As a result, the firm is focused on hair and beauty. These highly enriching and stimulating initiatives were positively reflected on the firm’s financial prospects, where cash hiked to £1.33m in 2021 from £0.15m in 2020. Despite the cash rally, the firm’s stock price is undervalued, as illustrated by its low P/E ratio of 14.9x, which is relatively below the consumer staples P/E ratio of 27.31x, hence it is cheaply available for investors to buy the stock. Consequently, it implies that InnovaDerma is trading at a discount with respect to its peers and is likely to soar since its P/B stood at 2.34x. Brief Analysis: P/E = 14.9, below sector benchmark. P/B = 2.34, above industry threshold. Net cash of £1.33m, higher than prior year.... ...from WealthOracle |
Posted at 31/3/2022 11:50 by km18 InnovaDerma plc comprises departments engaged in developing clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation. As a result, the firm is focused on hair and beauty. These highly enriching and stimulating initiatives were positively reflected on the firm’s financial prospects, where cash hiked to £1.33m in 2021 from £0.15m in 2020. Despite the cash rally, the firm’s stock price is undervalued, as illustrated by its low P/E ratio of 14.9x, which is relatively below the consumer staples P/E ratio of 27.31x, hence it is cheaply available for investors to buy the stock. Consequently, it implies that InnovaDerma is trading at a discount with respect to its peers and is likely to soar since its P/B stood at 2.34x.Keep up to date with WealthOracle |
Posted at 28/1/2022 07:44 by se81 Yesterday’s AGM (and presentation) via investor meet company available- the sales trajectory via Amazon in the quiet months looks v interesting |
Posted at 30/12/2021 11:58 by beetroot juice Big Afternoon coming for IDP. Expect another Holding RNS from MR WARD.These about to Fly. Still trying for another 100k. But if I don't get them, its cool I got plenty. Great to see IDP moving on to investors radars once more. |
Posted at 29/12/2021 10:25 by blueshoes7 Main thing is confidence has returned. Half year results to show trading profitably with increased Turnover. Which I suspect will be the case will see, IDP back on a lot of investors favourite list.The Low Mkt cap and minimal shares in issue make this a great stock for 2022. |
Posted at 23/12/2021 14:09 by gregpeck7 Really good to publish InnovaDerma’s results this week, these can be found by following the link at the bottom of this post.I’ve been an investor in InnovaDerma for some time and joined the board when it became obvious that the company was significantly lacking both strategic direction and operational focus. Whilst some of the issues were very obvious from the outside, it was only when I joined the board that the full extent of the problems became apparent. It was clear immediately that we needed to refresh the board and install a new executive management team who would ensure that InnovaDerma’s full potential could be met and that the company was run for the benefit of it’s shareholders, employees and consumers. We implemented the board and executive management changes quickly and whilst the sheer scale of historic issues has meant it’s taken longer than anticipated, we have now successfully revamped, refocused and reinvigorated the company. A huge amount has changed over the past 12 months : · We’ve resolved and reversed some incorrect and inappropriate accounting treatment which had been going on for years. · We’ve focused on profitable revenue, as opposed to just growing revenue at any cost. · We’ve significantly improved our gross margin by well over 1,000 basis points. · We’ve refreshed our DTC offering, our websites and our social media platforms whilst also entering into a strategic relationship with Amazon which has already generated material returns. · We’ve entered into an influencer partnership with Liberty Poole, a popular Love Island contestant with over 1.5m followers, to ensure we can target an enlarged demographic for our Skinny Tan brand. · We’ve significantly overhauled our operations and logistics to ensure that our consumers actually receive the products that they order within the timescales they expect, we’ve also increased the quality of these products to ensure that over 75% of our consumers give us a 5* rating. · We’ve significantly simplified the company and implemented robust management information systems to ensure we fully understand our business performance in near real time. · We’ve significantly cut down our spend on expensive 3rd party contractors and we’ve absolutely stopped money being paid to 3rd parties where there has been little or no obvious benefit to the company. · We’ve engaged new UK based auditors and professional advisors to ensure we’re ready for our next phase of profitable growth. · Etc etc I could go on and on however without doubt our biggest achievement has been unleashing our team to reach their full potential, InnovaDerma have a skilled, engaged and passionate workforce who now have the strategic direction and focus to achieve great things. In short, almost every aspect of the business has been improved upon over the past year and we go into 2022 as a strong company with a bright future. I’m particularly excited about the advances we’ve made with regards to new product development. InnovaDerma, and in particular our Skinny Tan brand, has always been known for it’s great product range and our team will be launching some amazing and innovative new products over the next 12 to 24 months. I would like to take this opportunity to thank the entire InnovaDerma team for their hard work and dedication over what has been a very challenging period, it’s been tough but our best days are just ahead of us. I would also like to thank our long suffering and supportive shareholders, I feel your pain and I’m confident we now have the right strategy and the right team to ensure InnovaDerma reaches it’s full potential. As a management team we are now 100% focused on doing what is in the best interests of our shareholders and ensuring we generate meaningful returns for them. We still have a long way to go to ensure we’re truly best in class however I’m confident that we’ll get there. Have a great Xmas! Mark. hxxps://www.innovade |
Posted at 02/12/2021 11:07 by brumm1875 Very thin volumes so it only takes a few sellers to crash the share price. Investors still waiting for the FY 2021 (to end June) results to be released. They missed the September legal deadline but got an extension due to covid & change of auditors. Investors braced for a big write down of assets, kitchen sink exercise, and see how the business is doing under the new management. At these levels, expectations are very low so reckon some good upside if they can show they mean business. |
Posted at 02/9/2021 12:21 by idriveajag Amazon and Neon Management promos will only increase sales even more. New management team know how to manage properly.Should be a great 12 months ahead for the company and investors. |
Posted at 15/4/2021 16:06 by lord loads of lolly muzmanoz - Think I read £4m of the £4.5m open offer (i.e the total available to NON-PIs) was oversubscribed. In which case administration ain't on the cards (not yet at least). It's an interesting one. I plan to wait until the very last moment (22 April) to see how the share price moves before deciding whether to take up. I'm inclined to double up because 1) Having rejected Creightons' offer out of hand, management must either be incredibly confident they can do better themselves - or hopelessly arrogant. 2) Late last year, NED Mark Ward bought another £270K worth of shares at 70p each. OK, so his timing wasn't great. But he's certainly no slouch. He's also a multi-millionaire from the takeover of his former empire (Hunter Macdonald) and is a real IT whizz which bodes well for IDP. As of Feb 21, he held 12.5% or just shy of 17.4 million IDP shares. And I believe following the open offer, his total holding will be just north of 13%. I've been saying for a while my biggest fear is if he takes IDP private before it's fully recovered (assuming it ever does), then enjoys most of the upside at the expense of long-suffering small investors. I believe that's still a big risk, as the company seems quite dependent on him to bankroll things short-term. But hopefully the open offer will change that. My other main concern is that with peak tanning season running from now to end June, and lockdown only gradually being eased, full year results may disappoint. But as others have said, with fewer people flying off to sunnier climes this summer, there may be increased demand for self tanning products given the vagaries of our British summer. |
Posted at 04/3/2021 19:56 by boonkoh Thanks!Confirms my suspicion that this is unloved by some investors, which is great because it means I got it cheap rather than overpaying for a story stock.Meanwhile if you bother to look, you'll see new management and a new strategy, and know that it is not the Innovaderma of before. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
